Education
About Us
Working with TipRanks
Follow Us
Malte Peters Insider Profile
4 Followers
Malte Peters, President & CEO, Director at Tango Therapeutics, holds 367.50K shares in Tango Therapeutics (Ticker: TNGX), holds 54.35K shares in Hookipa Pharma (Ticker: HOOK).
Malte Peters Tango Therapeutics (TNGX)President & CEO, Director
Tango Therapeutics (TNGX)
President & CEO, Director
Ranked #48,690 out of 105,518 Corporate Insiders
Profitable Transactions
2 out of 2 Profitable Transactions
Average Return
+6.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Malte Peters holds in companies
Most Profitable Insider Trade
The most profitable trade made by Malte Peters
Malte Peters's Trading History
Tango Therapeutics
Jan 12, 2026
President & CEO, Director
Uninformative Buy
―
$4.78M
Hookipa Pharma
Oct 09, 2025
CEO, Director
Informative Sell
20.64K
$50.81K
List of latest transactions for each holding click on a transaction to see Malte Peters's performance on stock
You May Also Like
Malte Peters insider profile FAQ
What is the percentage of profitable transactions made by Malte Peters?
The percentage of profitable transactions made by Malte Peters is 100%.
What is the average return per transaction made by Malte Peters?
The average return per transaction made by Malte Peters is 6.40%.
What stocks does Malte Peters hold?
Malte Peters holds: TNGX, HOOK stocks.
What was Malte Peters’s latest transaction?
Malte Peters latest transaction was an Uninformative Buy of ―.
What was Malte Peters's most profitable transaction?
Malte Peters’s most profitable transaction was an Informative Sell of HOOK stock on July 23, 2025. The return on the trade was 8.50%.
What is Malte Peters's role in Tango Therapeutics?
Malte Peters's role in Tango Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.